Balyasny Asset Management LLC Neuronetics, Inc. Transaction History
Balyasny Asset Management LLC
- $61.9 Billion
- Q2 2025
A detailed history of Balyasny Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,509,099 shares of STIM stock, worth $5.83 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,509,099
Previous 1,417,051
6.5%
Holding current value
$5.83 Million
Previous $5.21 Million
1.0%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding STIM
# of Institutions
97Shares Held
18.6MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$10.6 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.71 Million1.44% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.24 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.86 Million0.14% of portfolio
-
Manatuck Hill Partners, LLC Westport, CT920KShares$3.55 Million1.29% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $104M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...